Toronto Dominion Bank’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-765
Closed -$1.09K 1740
2023
Q3
$1.09K Hold
765
﹤0.01% 1408
2023
Q2
$1K Buy
+765
New +$903 ﹤0.01% 1443
2018
Q3
Sell
-60
Closed -$1K 1539
2018
Q2
$1K Buy
+60
New +$1.01K ﹤0.01% 1419
2016
Q1
Sell
-1,009
Closed -$30K 1272
2015
Q4
$30K Hold
1,009
﹤0.01% 945
2015
Q3
$32K Hold
1,009
﹤0.01% 929
2015
Q2
$49K Sell
1,009
-37
-4% -$1.56K ﹤0.01% 949
2015
Q1
$45K Hold
1,046
﹤0.01% 929
2014
Q4
$27K Buy
+1,046
New +$22.9K ﹤0.01% 935

Other funds holding PGEN

Toronto Dominion Bank's PGEN Position: Q4 2023 in Review

Toronto Dominion Bank sold out of Precigen (PGEN) in Q4 2023, closing a stake of 765 shares — an estimated $1.09K sold.

Toronto Dominion Bank first reported a position in PGEN in Q4 2014 and held it in 8 quarters. The position peaked at $49K in Q2 2015. 137 funds tracked by Wall St. Rank hold PGEN as of Q4 2023.

  • Toronto Dominion Bank reported no remaining Precigen position as of Q4 2023 after selling out during the quarter.
  • Toronto Dominion Bank sold 765 Precigen shares in Q4 2023, an estimated $1.09K.
  • Toronto Dominion Bank first reported a position in Precigen in Q4 2014 and held it in 8 quarters.
  • Toronto Dominion Bank's Precigen position peaked at $49K in Q2 2015.
  • 137 funds tracked by Wall St. Rank held Precigen as of Q4 2023.

Based on Toronto Dominion Bank's 13F filing for Q4 2023, filed 13 Feb 2024.